Pharmacotherapy for Neuropsychiatric Symptoms in Frontotemporal Dementia

被引:0
|
作者
Christine Le
Elizabeth Finger
机构
[1] University of Western Ontario,Department of Clinical Neurological Sciences, Schulich School of Medicine and Dentistry
来源
CNS Drugs | 2021年 / 35卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Despite significant progress in the understanding of the frontotemporal dementias (FTDs), there remains no disease-modifying treatment for these conditions, and limited effective symptomatic treatment. Behavioural variant frontotemporal dementia (bvFTD) is the most common FTD syndrome, and is characterized by severe impairments in behaviour, personality and cognition. Neuropsychiatric symptoms are common features of bvFTD but are present in the other FTD syndromes. Current treatment strategies therefore focus on ameliorating the neuropsychiatric features. Here we review the rationale for current treatments related to each of the main neuropsychiatric symptoms forming the diagnostic criteria for bvFTD relevant to all FTD subtypes, and two additional symptoms not currently part of the diagnostic criteria: lack of insight and psychosis. Given the paucity of effective treatments for these symptoms, we highlight how contributing mechanisms delineated in cognitive neuroscience may inform future approaches to clinical trials and more precise symptomatic treatments for FTDs.
引用
收藏
页码:1081 / 1096
页数:15
相关论文
共 50 条
  • [1] Pharmacotherapy for Neuropsychiatric Symptoms in Frontotemporal Dementia
    Le, Christine
    Finger, Elizabeth
    [J]. CNS DRUGS, 2021, 35 (10) : 1081 - 1096
  • [2] Antipsychotic Pharmacotherapy for Neuropsychiatric Symptoms of Dementia
    Golas A.C.
    Fischer C.E.
    [J]. Current Treatment Options in Psychiatry, 2018, 5 (1) : 56 - 72
  • [3] Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USA
    Stephanie V. Phan
    Sharmon Osae
    John C. Morgan
    Mfon Inyang
    Susan C. Fagan
    [J]. Drugs in R&D, 2019, 19 : 93 - 115
  • [4] Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USA
    Phan, Stephanie V.
    Osae, Sharmon
    Morgan, John C.
    Inyang, Mfon
    Fagan, Susan C.
    [J]. DRUGS IN R&D, 2019, 19 (02) : 93 - 115
  • [5] Pharmacotherapy of dementia and other neuropsychiatric symptoms in Parkinson disease
    Mollenhauer, Brit
    Wenzel, Sascha
    Trenkwalder, Claudia
    [J]. ZEITSCHRIFT FUR PSYCHIATRIE PSYCHOLOGIE UND PSYCHOTHERAPIE, 2008, 56 (01): : 13 - 18
  • [6] Pharmacotherapy for Frontotemporal Dementia
    Rita Khoury
    Yu Liu
    Quratulanne Sheheryar
    George T. Grossberg
    [J]. CNS Drugs, 2021, 35 : 425 - 438
  • [7] Pharmacotherapy for Frontotemporal Dementia
    Khoury, Rita
    Liu, Yu
    Sheheryar, Quratulanne
    Grossberg, George T.
    [J]. CNS DRUGS, 2021, 35 (04) : 425 - 438
  • [8] Frequency and course of behavioural and neuropsychiatric symptoms in genetic frontotemporal dementia
    Schoenecker, S.
    Martinez-Murcia, F. J.
    Franzmeier, N.
    Denecke, J.
    Bernhard, A.
    Wagemann, O.
    Wlasich, E.
    Hoeglinger, G. U.
    Van Swieten, J. C.
    Moreno, F.
    Otto, M.
    Laforce, R.
    Graff, C.
    Masellis, M.
    Tartaglia, M. Carmela
    Rowe, J. B.
    Borroni, B.
    Finger, E.
    Synofzik, M.
    Galimberti, D.
    Vandenberghe, R.
    De Mendonca, A.
    Ducharme, S.
    Rohrer, J. D.
    Levin, J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 111 - 112
  • [9] Neuropsychiatric Symptoms in Frontotemporal Dementia: More Than Just Noise?
    Altomare, Daniele
    Rivolta, Jasmine
    Libri, Ilenia
    Mattioli, Irene
    Cantoni, Valentina
    Padovani, Alessandro
    Borroni, Barbara
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2024, 98 (01) : 133 - 144
  • [10] Relations with neuropsychiatric symptoms and activity of daily living in frontotemporal dementia
    Kawahara, Kazuhiro
    Fukuhara, Ryuji
    Miyagawa, Yusuke
    Hatada, Yutaka
    Tanaka, Hibiki
    Hashimoto, Mamoru
    Ikeda, Manabu
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2015, 27 : S144 - S145